Srinivas Pillai

681 total citations
11 papers, 169 citations indexed

About

Srinivas Pillai is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Srinivas Pillai has authored 11 papers receiving a total of 169 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 4 papers in Hematology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Srinivas Pillai's work include Chronic Lymphocytic Leukemia Research (5 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Srinivas Pillai is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Srinivas Pillai collaborates with scholars based in United Kingdom, Spain and Germany. Srinivas Pillai's co-authors include A R Zander, Charles Craddock, Rainer Schwerdtfeger, Jürgen Finke, Mohamad Mohty, Stefanie Buchholz, Emmanuelle Polge, Vanderson Rocha, Myriam Labopin and Hildegard Greinix and has published in prestigious journals such as Blood, PLoS ONE and Annals of Oncology.

In The Last Decade

Srinivas Pillai

10 papers receiving 169 citations

Peers

Countries citing papers authored by Srinivas Pillai

Since Specialization

Citations

This map shows the geographic impact of Srinivas Pillai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srinivas Pillai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srinivas Pillai more than expected).

Fields of papers citing papers by Srinivas Pillai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Srinivas Pillai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srinivas Pillai. The network helps show where Srinivas Pillai may publish in the future.

Co-authorship network of co-authors of Srinivas Pillai

This figure shows the co-authorship network connecting the top 25 collaborators of Srinivas Pillai. A scholar is included among the top collaborators of Srinivas Pillai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Srinivas Pillai. Srinivas Pillai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Fourier Transform Infrared microspectroscopy identifies single cancer cells in blood. A feasibility study towards liquid biopsy 2023 ·PLoS ONE ·(unknown), Paul Roach, (unknown), Achim Köhler, Srinivas Pillai, Daniel Gey van Pittius, Ibraheem Yousef, Josep Sulé‐Suso	3
2	Optimization of Sample Preparation Using Glass Slides for Spectral Pathology 2020 ·Applied Spectroscopy ·(unknown), Paul Roach, (unknown), Ibraheem Yousef, Srinivas Pillai, (unknown), Daniel Gey van Pittius, Josep Sulé‐Suso	7
3	THE EFFICACY OF IBRUTINIB IN PATIENTS WITH RELAPSED MANTLE CELL LYMPHOMA AFTER FIRST LINE INTENSIVE CHEMO‐IMMUNOTHERAPY AND ASCT – A RETROSPECTIVE STUDY FROM THE LWP‐EBMT 2019 ·Hematological Oncology ·(unknown), Stephen Robinson, Ariane Boumendil, Hervé Finel, (unknown), (unknown), Xavier Poiré, Bruno Lioure, Karl S. Peggs, Robin Foà, Srinivas Pillai, Tom van Meerten, (unknown), Christoph Schmid, Valentijn Vergote, Arnold Ganser, Luca Castagna, G J Mufti, Silvia Montoto	0
4	Ibrutinib for Relapsed Mantle Cell Lymphoma after Standard First Line Therapy and ASCT Is Efficacious but Does Not Overcome the Impact of POD24 - a Retrospective Study from the LWP-EBMT 2019 ·Blood ·(unknown), Stephen Robinson, Ariane Boumendil, Hervé Finel, (unknown), Hannah Hunter, Xavier Poiré, Bruno Lioure, Karl S. Peggs, Robin Foà, Srinivas Pillai, Tom van Meerten, Juan Bargay, Christoph Schmid, (unknown), Arnold Ganser, Luca Castagna, Ghulam J. Mufti, Silvia Montoto	2
5	Vorinostat Does Not Improve Outcome in Patients with Acute Myeloid Leukemia and High Risk Myelodysplasia Treated with Azacitidine: Results of the UK Trials Acceleration Programme Ravva Trial 2016 ·Blood ·Charles Craddock, Aimee E. Houlton, Paul Ferguson, Manoj Raghavan, Sonia Fox, Louise Dudley, Lynn Quek, Jamie Cavenagh, Michael Dennis, Mary Frances McMullin, Srinivas Pillai, Richard Kelly, Shamyla Siddique, Keith Wheatley, Paresh Vyas	3
6	Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia 2011 ·Leukemia ·Charles Craddock, Myriam Labopin, Srinivas Pillai, Jürgen Finke, Donald Bunjes, Hildegard Greinix, Gerhard Ehninger, (unknown), A R Zander, Rainer Schwerdtfeger, Stefanie Buchholz, HJ Kolb, Liisa Volin, A. A. Fauser, Emmanuelle Polge, Christoph Schmid, Mohamad Mohty, Vanderson Rocha	94
7	Does reduced-intensity allogeneic transplantation confer a survival advantage to patients with poor prognosis chronic lymphocytic leukaemia? A case–control retrospective analysis 2009 ·Annals of Oncology ·Julio Delgado, Srinivas Pillai, (unknown), Salut Brunet, Guy Pratt, Javier Briones, Richard Lovell, Rodrigo Martino, (unknown), Anna Sureda, D W Milligan, Jorge Sierra	15
8	The Effect of In Vivo T Cell Depletion with Alemtuzumab on Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia 2008 ·Biology of Blood and Marrow Transplantation ·Julio Delgado, Srinivas Pillai, Reuben Benjamin, Dolores Caballero, Rodrigo Martino, Amit Nathwani, Richard Lovell, Kirsty Thomson, Josè Antonio Pérez-Simón, Anna Sureda, Panagiotis Kottaridis, Lourdes Vázquez, Karl S. Peggs, Jorge Sierra, Donald Milligan, Stephen Mackinnon	40
9	The Effect of In Vivo T-Cell Depletion with Alemtuzumab on Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia. 2007 ·Blood ·Julio Delgado, Srinivas Pillai, Reuben Benjamin, Dolores Caballero, Rodrigo Martino, Richard Lovell, Kirsty Thomson, Josè Antonio Pérez-Simón, Anna Sureda, (unknown), Jesús F. San Miguel, Karl S. Peggs, Jorge Sierra, Donald Milligan, Stephen Mackinnon	2
10	Filgrastim for the treatment of immune neonatal neutropenia. 1995 ·Blood ·(unknown), Peter H. Gray, (unknown), DI Tudehope, (unknown), R. M. Minchinton, (unknown), (unknown), (unknown), (unknown), Srinivas Pillai	1
11	X‐ray diffraction by hairs and feathers. Part I 1960 ·Journal of Applied Polymer Science ·K. Venkateswarlu, Srinivas Pillai	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact